• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MyD88 缺乏症可改善阿尔茨海默病动物模型中的β-淀粉样蛋白沉积。

MyD88 deficiency ameliorates β-amyloidosis in an animal model of Alzheimer's disease.

机构信息

Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, Illinois, USA.

出版信息

Am J Pathol. 2011 Sep;179(3):1095-103. doi: 10.1016/j.ajpath.2011.05.045. Epub 2011 Jul 19.

DOI:10.1016/j.ajpath.2011.05.045
PMID:21763676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3157279/
Abstract

The accumulation of β-amyloid protein (Aβ) in the brain is thought to be a primary etiologic event in Alzheimer's disease (AD). Fibrillar Aβ plaques, a hallmark of AD abnormality, are closely associated with activated microglia. Activated microglia have contradictory roles in the pathogenesis of AD, being either neuroprotective (by clearing harmful Aβ and repairing damaged tissues) or neurotoxic (by producing proinflammatory cytokines and reactive oxygen species). Aβ aggregates can activate microglia by interacting with multiple toll-like receptors (TLRs), the pattern-recognition receptors of the innate immune system. Because the adapter protein MyD88 is essential for the downstream signaling of all TLRs, except TLR3, we investigated the effects of MyD88 deficiency (MyD88(-/-)) on Aβ accumulation and microglial activation in an AD mouse model. MyD88 deficiency decreased Aβ load and microglial activation in the brain. The decrease in Aβ load in an MyD88(-/-) AD mouse model was associated with increased and decreased protein expression of apolipoprotein E (apoE) and CX3CR1, respectively, compared with that in an MyD88 wild-type AD mouse model. These results suggest that MyD88 deficiency may reduce Aβ load by enhancing the phagocytic capability of microglia through fractalkine (the ligand of CX3CR1) signaling and by promoting apoE-mediated clearance of Aβ from the brain. These findings also suggest that chronic inflammatory responses induced by Aβ accumulation via the MyD88-dependent signaling pathway exacerbate β-amyloidosis in AD.

摘要

β-淀粉样蛋白(Aβ)在大脑中的积累被认为是阿尔茨海默病(AD)的主要病因。纤维状 Aβ 斑块是 AD 异常的标志,与活化的小胶质细胞密切相关。活化的小胶质细胞在 AD 的发病机制中具有矛盾的作用,既具有神经保护作用(通过清除有害的 Aβ 和修复受损组织),也具有神经毒性作用(通过产生促炎细胞因子和活性氧)。Aβ 聚集物可以通过与多种 Toll 样受体(TLRs)相互作用来激活小胶质细胞,TLRs 是先天免疫系统的模式识别受体。由于适配器蛋白 MyD88 是除 TLR3 之外所有 TLR 下游信号转导所必需的,因此我们研究了 MyD88 缺失(MyD88(-/-))对 AD 小鼠模型中 Aβ 积累和小胶质细胞激活的影响。MyD88 缺失可减少大脑中的 Aβ 负荷和小胶质细胞激活。与 MyD88 野生型 AD 小鼠模型相比,MyD88(-/-)AD 小鼠模型中的 Aβ 负荷减少与载脂蛋白 E(apoE)和 CX3CR1 的蛋白表达分别增加和减少有关。这些结果表明,MyD88 缺失可能通过 fractalkine(CX3CR1 的配体)信号增强小胶质细胞的吞噬能力,并通过促进 apoE 介导的 Aβ 从大脑中的清除来减少 Aβ 负荷。这些发现还表明,通过 MyD88 依赖性信号通路累积 Aβ 引起的慢性炎症反应会加剧 AD 中的β-淀粉样蛋白沉积。

相似文献

1
MyD88 deficiency ameliorates β-amyloidosis in an animal model of Alzheimer's disease.MyD88 缺乏症可改善阿尔茨海默病动物模型中的β-淀粉样蛋白沉积。
Am J Pathol. 2011 Sep;179(3):1095-103. doi: 10.1016/j.ajpath.2011.05.045. Epub 2011 Jul 19.
2
MyD88 is dispensable for cerebral amyloidosis and neuroinflammation in APP/PS1 transgenic mice.髓样分化因子88(MyD88)在APP/PS1转基因小鼠的脑淀粉样变性和神经炎症中并非必需。
Am J Pathol. 2014 Nov;184(11):2855-61. doi: 10.1016/j.ajpath.2014.07.004. Epub 2014 Aug 28.
3
Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?CX3CR1和趋化因子在阿尔茨海默病(AD)啮齿动物模型中对β淀粉样蛋白清除及磷酸化tau蛋白积累的影响:趋化因子是AD的全身性生物标志物吗?
Curr Alzheimer Res. 2016;13(4):403-12. doi: 10.2174/1567205013666151116125714.
4
CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.CX3CR1 缺失改变小胶质细胞激活并减少两种阿尔茨海默病小鼠模型中的 β-淀粉样蛋白沉积。
Am J Pathol. 2010 Nov;177(5):2549-62. doi: 10.2353/ajpath.2010.100265. Epub 2010 Sep 23.
5
TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease.TLR4 突变可减少小胶质细胞激活,增加 Aβ 沉积,并加重阿尔茨海默病小鼠模型的认知缺陷。
J Neuroinflammation. 2011 Aug 9;8:92. doi: 10.1186/1742-2094-8-92.
6
Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice.小胶质细胞 CX3CR1 杂合缺失恢复神经元 β-淀粉样蛋白清除途径并减缓 PS1-APP 小鼠阿尔茨海默病样疾病的进展。
Front Immunol. 2019 Dec 2;10:2780. doi: 10.3389/fimmu.2019.02780. eCollection 2019.
7
Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.纤维状 Aβ 在阿尔茨海默病小鼠模型中引发小胶质细胞蛋白质组改变和功能障碍。
Elife. 2020 Jun 8;9:e54083. doi: 10.7554/eLife.54083.
8
Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression.在衰老过程中,野生型小鼠小胶质细胞对脂多糖的反应增强,但在阿尔茨海默病小鼠模型中则减弱:Toll样受体4信号在疾病进展中的意义。
Biochem Biophys Res Commun. 2016 Oct 14;479(2):331-337. doi: 10.1016/j.bbrc.2016.09.073. Epub 2016 Sep 15.
9
Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease.纤维状β淀粉样肽通过Toll样受体2激活小胶质细胞:对阿尔茨海默病的影响
J Immunol. 2008 Nov 15;181(10):7254-62. doi: 10.4049/jimmunol.181.10.7254.
10
Role of toll-like receptor signalling in Abeta uptake and clearance.Toll样受体信号通路在β淀粉样蛋白摄取和清除中的作用。
Brain. 2006 Nov;129(Pt 11):3006-19. doi: 10.1093/brain/awl249. Epub 2006 Sep 19.

引用本文的文献

1
Association Between the Gut Microbiota and Alzheimer's Disease: An Update on Signaling Pathways and Translational Therapeutics.肠道微生物群与阿尔茨海默病之间的关联:信号通路与转化治疗的最新进展
Mol Neurobiol. 2025 Apr;62(4):4499-4519. doi: 10.1007/s12035-024-04545-2. Epub 2024 Oct 26.
2
Immune senescence in aged APP/PS1 mice.老年APP/PS1小鼠的免疫衰老
NeuroImmune Pharm Ther. 2023 Aug 14;2(3):317-330. doi: 10.1515/nipt-2023-0015. eCollection 2023 Sep.
3
Bridging the Gap between Gut Microbiota and Alzheimer's Disease: A Metaproteomic Approach for Biomarker Discovery in Transgenic Mice.肠道微生物群与阿尔茨海默病之间的桥梁:一种用于转基因小鼠生物标志物发现的代谢蛋白质组学方法。
Int J Mol Sci. 2023 Aug 15;24(16):12819. doi: 10.3390/ijms241612819.
4
Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease.Toll 样受体 4:阿尔茨海默病有前途的治疗靶点。
Mediators Inflamm. 2022 Aug 21;2022:7924199. doi: 10.1155/2022/7924199. eCollection 2022.
5
Supramolecular organizing centers at the interface of inflammation and neurodegeneration.炎症与神经退行性变界面处的超分子组织中心。
Front Immunol. 2022 Aug 1;13:940969. doi: 10.3389/fimmu.2022.940969. eCollection 2022.
6
Increased MYD88 blood transcript in a mouse model of Alzheimer's disease.阿尔茨海默病小鼠模型中 MYD88 血液转录物增加。
BMC Neurosci. 2022 Mar 11;23(1):13. doi: 10.1186/s12868-022-00699-8.
7
Protective Effects of JA845 against D-Galactose/AlCl-Induced Cognitive Decline, Oxidative Stress and Neuroinflammation.JA845 对 D-半乳糖/AlCl 诱导的认知衰退、氧化应激和神经炎症的保护作用。
J Microbiol Biotechnol. 2022 Feb 28;32(2):212-219. doi: 10.4014/jmb.2111.11031.
8
Transcriptional signature in microglia associated with Aβ plaque phagocytosis.与 Aβ 斑块吞噬作用相关的小胶质细胞转录特征。
Nat Commun. 2021 May 21;12(1):3015. doi: 10.1038/s41467-021-23111-1.
9
Dysbiosis and Alzheimer's Disease: A Role for Chronic Stress?肠道菌群失调与阿尔茨海默病:慢性应激的作用?
Biomolecules. 2021 Apr 30;11(5):678. doi: 10.3390/biom11050678.
10
TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.TLR4 与 NLRP3 炎性小体及补体信号通路在阿尔茨海默病中的相互作用。
Front Immunol. 2020 Apr 23;11:724. doi: 10.3389/fimmu.2020.00724. eCollection 2020.

本文引用的文献

1
Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment?炎症反应是否先于阿尔茨海默病和轻度认知障碍?
Curr Alzheimer Res. 2011 Mar;8(2):164-74. doi: 10.2174/156720511795255982.
2
CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis.小胶质细胞中的 CX3CR1 通过选择性原纤维态淀粉样蛋白-β吞噬作用调节脑淀粉样蛋白沉积。
J Neurosci. 2010 Dec 15;30(50):17091-101. doi: 10.1523/JNEUROSCI.4403-10.2010.
3
Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.髓样分化因子 88 缺陷的骨髓细胞可改善阿尔茨海默病相关症状和病理。
Brain. 2011 Jan;134(Pt 1):278-92. doi: 10.1093/brain/awq325. Epub 2010 Nov 28.
4
CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.CX3CR1 缺失改变小胶质细胞激活并减少两种阿尔茨海默病小鼠模型中的 β-淀粉样蛋白沉积。
Am J Pathol. 2010 Nov;177(5):2549-62. doi: 10.2353/ajpath.2010.100265. Epub 2010 Sep 23.
5
Pattern recognition receptors and inflammation.模式识别受体与炎症。
Cell. 2010 Mar 19;140(6):805-20. doi: 10.1016/j.cell.2010.01.022.
6
Microglia and inflammation in Alzheimer's disease.小胶质细胞与阿尔茨海默病中的炎症反应。
CNS Neurol Disord Drug Targets. 2010 Apr;9(2):156-67. doi: 10.2174/187152710791012071.
7
APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.阿尔茨海默病的 APP 转基因建模:神经退行性变和异常神经发生的机制。
Brain Struct Funct. 2010 Mar;214(2-3):111-26. doi: 10.1007/s00429-009-0232-6. Epub 2009 Nov 29.
8
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer.CD36 配体通过组装 Toll 样受体 4 和 6 异源二聚体促进无菌性炎症。
Nat Immunol. 2010 Feb;11(2):155-61. doi: 10.1038/ni.1836. Epub 2009 Dec 27.
9
Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid {beta} neurotoxicity in in vitro and in vivo models of Alzheimer's disease.小胶质细胞经 Toll 样受体 9 配体 CpG 激活后,可减轻阿尔茨海默病体外和体内模型中寡聚淀粉样蛋白 β 的神经毒性。
Am J Pathol. 2009 Nov;175(5):2121-32. doi: 10.2353/ajpath.2009.090418. Epub 2009 Oct 15.
10
CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation.原纤维Aβ刺激的小胶质细胞激活需要CD14以及Toll样受体2和4。
J Neurosci. 2009 Sep 23;29(38):11982-92. doi: 10.1523/JNEUROSCI.3158-09.2009.